1. Home
  2. CNF vs ONMD Comparison

CNF vs ONMD Comparison

Compare CNF & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNF

CNFinance Holdings Limited each representing twenty (20)

N/A

Current Price

$2.03

Market Cap

32.7M

Sector

Finance

ML Signal

N/A

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$5.64

Market Cap

29.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CNF
ONMD
Founded
1999
2006
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
29.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
CNF
ONMD
Price
$2.03
$5.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.5K
★ 27.1K
Earning Date
08-28-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 83.33
EPS
★ N/A
N/A
Revenue
N/A
★ $1,359,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 111.35
52 Week Low
$1.37
$0.63
52 Week High
$6.49
$115.00

Technical Indicators

Market Signals
Indicator
CNF
ONMD
Relative Strength Index (RSI) 59.04 42.87
Support Level $1.74 $3.86
Resistance Level $2.19 $39.25
Average True Range (ATR) 0.12 0.52
MACD 0.02 0.85
Stochastic Oscillator 76.74 76.08

Price Performance

Historical Comparison
CNF
ONMD

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: